This inventor holds 4 USPTO granted patents. Top assignee: Columbia University. Active years: 1992-2000.
Company Filing History:
Years Active: 1992-2000
Title: J Steven McDougal: Innovator in Immunology
Introduction
J Steven McDougal is a prominent inventor based in Atlanta, GA, known for his significant contributions to the field of immunology. He holds a total of four patents, showcasing his innovative approach to addressing critical health challenges.
Latest Patents
Among his latest patents is a groundbreaking invention related to DNA encoding the T cell surface protein T4. This invention provides an isolated single-stranded nucleic acid that encodes an aqueous-soluble polypeptide, which specifically forms a complex with a human immunodeficiency virus envelope glycoprotein. Another notable patent involves a single-stranded nucleic acid molecule that encodes an amino acid sequence comprising at least a portion of a T4 glycoprotein. These amino acid sequences are designed to serve as a prophylaxis for treating subjects with acquired immune deficiency syndrome. They are capable of blocking the human immunodeficiency virus from binding to T4.sup.+ cells. Additionally, monoclonal antibodies directed to these water-soluble amino acid sequences may be utilized as vaccines for immunizing subjects against acquired immune deficiency syndrome.
Career Highlights
J Steven McDougal is affiliated with Columbia University, where he continues to advance research in immunology and related fields. His work has had a profound impact on the understanding and treatment of diseases associated with the human immunodeficiency virus.
Collaborations
Throughout his career, McDougal has collaborated with notable colleagues, including Paul J Maddon and Dan R Littman, further enhancing the scope and impact of his research.
Conclusion
J Steven McDougal's innovative work in immunology, particularly in relation to HIV, underscores his role as a leading inventor in the field. His patents reflect a commitment to developing solutions that could significantly improve health outcomes for individuals affected by serious diseases.